Posted on 12/21/20
Joe Biden to Receive First Dose of Pfizer/BioNTech Vaccine on Monday
The most high-profile American in 2021 is going to receive his initial dose of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine as 2020 fades away. President-Elect . . .
Posted on 12/21/20
Better Coronavirus Stock: Pfizer vs. BioNTech
Mercedes or Porsche? Steak or sushi? Two things can both be good but very different. For investors, the best coronavirus stock may depend on who's choosing. . . .
Posted on 12/21/20
Here's Why Pfizer's Vaccine Is So Important
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) became the first drugmakers to win U.S. emergency use authorization for their COVID-19 vaccine BNT162b2 over the weekend. On Monday, the first Americans . . .
Posted on 12/21/20
4 Reasons You Should Buy Pfizer Stock Right Now
The ongoing rollout of the first authorized coronavirus vaccine has heaps of everyday investors wondering if Pfizer (NYSE:PFE), the company credited with making it happen so . . .
Posted on 12/18/20
Why Didn't Pfizer Stock Jump More After Winning Authorization for Its COVID Vaccine?
Pfizer(NYSE:PFE) received great news last Thursday that an advisory committee to the U.S. Food and Drug Administration (FDA) overwhelmingly recommended Emergency Use Authorization (EUA) for its . . .
Posted on 12/17/20
SCYNEXIS Prices of $85 Million Public Offering of Common Stock
JERSEY CITY, N.J., Dec. 17, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the pricing of its underwritten public offering of common stock, pre-funded warrants . . .
Posted on 12/17/20
Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna
It might seem like everything is going well for COVID-19 vaccines right now. The first Americans have already been vaccinated with Pfizer's (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) . . .
Posted on 12/17/20
What Pfizer's Vaccine Authorization Means for Moderna
The U.S. Food and Drug Administration (FDA) granted Pfizer's (NYSE:PFE) coronavirus vaccine candidate Emergency Use Authorization (EUA) last week. On Dec. 17, the FDA will meet . . .
Posted on 12/17/20
3 Things Pfizer's Coronavirus Vaccine Still Has to Prove
The U.S. Food and Drug Administration met with its vaccines advisory panel of experts on Dec. 10 to discuss Pfizer's (NYSE:PFE) coronavirus vaccine candidate. The FDA . . .
Posted on 12/17/20
SCYNEXIS Announces Launch of $50 Million Public Offering of Common Stock
JERSEY CITY, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that it has commenced an underwritten public offering of shares of its . . .
Posted on 12/16/20
Which Is the Best COVID Vaccine Stock Now: Pfizer, BioNTech, or Moderna?
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently won U.S. emergency use authorization (EUA) for their COVID-19 vaccine. An EUA for Moderna's (NASDAQ:MRNA) vaccine could be only days away. In . . .
Posted on 12/16/20
AdaptHealth Prices $500M Senior Notes
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, . . .
Posted on 12/16/20
Philly Scientists Were Just Awarded $37.6M to Develop a COVID-19 Antibody Treatment
A collaborative team of scientists from institutions across Philadelphia and the country just received a $37.6
Posted on 12/15/20
Idera Pharmaceuticals Announces $5M In Further Proceeds from Private Placement of up to $20.7M
EXTON, Pa., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced the closing of a second tranche under its April 7, 2020, . . .
Posted on 12/15/20
Eli Lilly to Acquire Prevail Therapeutics
Eli Lilly and Company (NYSE: LLY) and Prevail Therapeutics Inc. (NASDAQ: PRVL) today announced a definitive agreement for Lilly to acquire Prevail for $22.50 per share . . .
Posted on 12/15/20
When Will Pfizer and Moderna Recognize COVID Vaccine Revenue?
Pfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) are waiting on pins and needles to receive emergency use authorizations (EUA) for their COVID-19 vaccines. And investors are anxiously awaiting the big . . .
Posted on 12/15/20
Here's Why Merck Made a Mistake by Selling Its Moderna Stake
Merck(NYSE:MRK) was one of the earliest investors in Moderna(NASDAQ:MRNA), buying a position in the biotech even before it went public in late 2018. Earlier this month, . . .
Posted on 12/15/20
Should the U.S. Have Bought More Doses of Pfizer's COVID Vaccine?
Reports emerged recently that the Trump administration turned down an opportunity to secure more doses of Pfizer(NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine, BNT162b2. In this Motley . . .
Posted on 12/14/20
AdaptHealth Proposed Offering of $500 Million Senior Notes
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, . . .
Posted on 12/14/20
Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update
BASKING RIDGE, N.J., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 12/14/20
Better Coronavirus Stock: Johnson & Johnson vs. Pfizer
Big problems tend to attract big problem solvers. So when a global pandemic first threatened the world earlier this year, it wasn't surprising that the two . . .
Posted on 12/14/20
FDA Authorizes Pfizer and BioNTech's Coronavirus Vaccine
Reviewers at the Food and Drug Administration (FDA) are working overtime these days. On Friday, the agency issued a late-evening emergency use authorization for Pfizer (NYSE:PFE) . . .
Posted on 12/14/20
Should Investors Buy Inovio for Its Coronavirus Vaccine?
Inovio Pharmaceuticals (NASDAQ:INO) is trailing the leaders with its coronavirus vaccine, INO-4800. Some of the slow start is tied to manufacturing issues for one of the . . .
Posted on 12/11/20
3 Reasons to Buy Pfizer Stock Now
The perception of a company can often be overwhelmed by the success of a single one of its products. Investors counting the tens of millions of . . .
Posted on 12/11/20
What Could Keep the FDA From Green Lighting Pfizer's and Moderna's Vaccines?
Pfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) await critical FDA advisory committee reviews for their respective COVID-19 vaccine candidates over the next two weeks. The prospects that both vaccines win . . .
Philadelphia
